AMSilk raised an additional €25 million in its Series C round led by ATHOS (AT Newtec), joined by Novo Holdings, Cargill, and MIG Capital via its MIG funds.

Biotech Health services Manufacturing

Investments

30 March 2023

AMSilk (company)

Biotech Health services Manufacturing

Total investments received (USD): 97.19m

Round value (USD): 27.2m

Round investors: Athos Service MIG Verwaltungs AG Novo A/S Cargill

Company: AMSilk

Industry: Biotech Health services Manufacturing

Health services Manufacturing Software Services

Investments 20 June 2023

Biotech Health services Pharma

Investments 15 April 2023

Hardware Health services Manufacturing Wearable

Investments 30 September 2022